With the rapid rise of hypertension and other cardiovascular disease, the cost for treatment in coming years will be staggering. With the Rimidi platform, clinicians are armed with better data to risk stratify patients, implement remote patient monitoring for those at the highest risk, and intervene with timely, guideline-based management via embedded clinical decision support cards—all helping to reduce the staggering cost attached to the condition
estimated cost of treating cardiovascular disease in half of U.S. population by 2035
of the US population is estimated to have some form of cardiovascular disease by 2035
Rimidi’s Approach to Heart Disease
Rimidi’s Cardiovascular Disease platform combines relevant EHR data with reliable, patient-generated blood pressure data from a cellular-enabled blood pressure cuff. Within the EHR workflow, Rimidi supports clinicians to manage better outcomes for patients with hypertension and other cardiovascular disease.
Combine Clinical and Patient-Generated Data
Rimidi aggregates the relevant patient data from the EHR and combines it with patient-generated blood pressure data from connected blood pressure cuffs. The blood pressure cuffs are cellular-enabled, meaning no technology syncing hassle or extra steps for the patient, and more reliable data for the provider.
Identify and Enable Remote Monitoring
Based on the enhanced dataset, Rimidi provides up-to-date risk stratification—identifying patients who are at high, medium, and low risk, enabling the clinical team to remotely monitor patients and intervene in a timely manner.
Intervene with Guideline-Based Management
Rimidi embeds clinical decision support cards within the clinician workflow, prompting a clinician (based on each patient’s unique data and the latest clinical guidelines and evidence) to adjust medications, send a patient for more imaging or bloodwork, or get the right patients referred to a specialist.